Remove Diabetes Remove Magazine Remove Vaccines
article thumbnail

Magazine: ‘Right shoring’ API production in Europe

Pharmaceutical Technology

Also in this month’s issue, we take a look at the innovative type 1 diabetes therapy by Provention Bio called Tzield. More than a century after an individual with type 1 diabetes was treated with insulin for the first time, the FDA approved Tzield, the first and only treatment to delay the onset of type 1 diabetes.

article thumbnail

Conducting successful commercial research in a primary care setting

pharmaphorum

To demonstrate how the NIHR CRN can help create such partnerships, Abraham detailed how the organisation partnered with Healum to research and understand the impact of its collaborative care software and app on condition management in the type 2 diabetes mellitus population in NHS primary care. moderator).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Emotional empathy is driving brand equity

pharmaphorum

New York Magazine , the New York Times and The Economist amongst many other news organisations knocked down their paywalls for COVID-19-related coverage to keep readers informed in a rapidly changing and often confusing environment. Think you need to build manufacturing of a vaccine before you know what’s working.

article thumbnail

A history of the pharmaceutical industry

pharmaphorum

The first was insulin – Frederick Banting and colleagues managed to isolate insulin that could treat diabetes, up until that point a fatal condition. George Merck on the cover of Time magazine. The period between 1918 and 1939 was marked by two breakthroughs that presaged the arrival of the pharma industry as we know it today.

Diabetes 145